English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/127100
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

An off-target nucleostemin RNAi inhibits growth in human glioblastoma-derived cancer stem cells

AuthorsGil-Ranedo, Jon CSIC ORCID; Mendiburu-Eliçabe, Marina; García-Villanueva, Mercedes; Medina, Diego; Álamo, Marta del; Izquierdo, Marta CSIC ORCID
Issue Date12-Dec-2011
PublisherPublic Library of Science
CitationPLoS ONE 6(12): e28753 (2011)
AbstractGlioblastomas (GBM) may contain a variable proportion of active cancer stem cells (CSCs) capable of self-renewal, of aggregating into CD133+ neurospheres, and to develop intracranial tumors that phenocopy the original ones. We hypothesized that nucleostemin may contribute to cancer stem cell biology as these cells share characteristics with normal stem cells. Here we report that nucleostemin is expressed in GBM-CSCs isolated from patient samples, and that its expression, conversely to what it has been described for ordinary stem cells, does not disappear when cells are differentiated. The significance of nucleostemin expression in CSCs was addressed by targeting the corresponding mRNA using lentivirally transduced short hairpin RNA (shRNA). In doing so, we found an off-target nucleostemin RNAi (shRNA22) that abolishes proliferation and induces apoptosis in GBM-CSCs. Furthermore, in the presence of shRNA22, GBM-CSCs failed to form neurospheres in vitro or grow on soft agar. When these cells are xenotransplanted into the brains of nude rats, tumor development is significantly delayed. Attempts were made to identify the primary target/s of shRNA22, suggesting a transcription factor involved in one of the MAP-kinases signaling-pathways or multiple targets. The use of this shRNA may contribute to develop new therapeutic approaches for this incurable type of brain tumor.
URIhttp://hdl.handle.net/10261/127100
DOIhttp://dx.doi.org/10.1371/journal.pone.0028753
Identifiersdoi: 10.1371/journal.pone.0028753
issn: 1932-6203
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
Izquierdo Marta An off target.pdf4,74 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.